|
⚲
|
| Keyboard |
| Typewriter Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002156390 |
| Sale | 2026-01-08 (56.3 M Offered, 56.3 M Sold) |
| Fund | |
| Phone | 6099239289 |
| Address | 238 Main Street, Office 2162 Cambridge, MA 02142 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-09-21 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Mikael Dolston | Director | |
| Laura Tadvalkar | Director | |
| Kenneth Horne | Director | |
| Matthew Stanton | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Tepper Robert I
✚
|
MA | |
|
Bogle Investment Management L P
✚
|
MA | |
|
Fletcher Spaght Inc
✚
|
MA | |
|
BCLS II Investco GP LLC
✚
|
MA | |
|
Amundi Pioneer Institutional Asset Management Inc
✚
|
MA | |
|
Robeco Investment Management Inc
✚
|
MA | |
|
Boston Hill Advisors LLC
✚
|
MA | |
|
Navemar Capital Management LP
✚
|
MA | |
|
Venus Capital Management Inc
✚
|
MA | |
|
Perennial Capital Advisors LLC
✚
|
MA |